Immunogenicity for Biotherapeutics 2014

The leading event for biologics de-risking, immunoassay validation
and predicting immunogenicity in novel, highly complex molecules
Thank you for your interest in our recent 14th Annual Immunogenicity for Biotherapeutics conference! This year's conference was a great success and featured:

• Three FDA keynote speakers- An in-depth insight from FDA regulators, featuring the release of draft guidelines for biosimilar development
• Immunogenicity University- Back by popular demand, this intensive full-day summit dives into the fundamentals of immunogenicity assessment, statistical analysis and assay design – beneficial for experts at all levels of their career
• Increased Networking Opportunities- You'll have 8+ hours of networking opportunity, including a Wine and Cheese Reception where scientists can link-up with lab technicians, research providers and regulatory consultants